← FDA DRUG APPROVALS

FDA NDA · NDA016401

NEOPAP

Sponsor: POLYMEDICA

APPLICATION
NDA016401
TYPE
NDA
ORIGINAL APPROVAL
1968-11-07
LATEST ACTION
1978-10-16
ROUTE
RECTAL
DOSAGE FORM
SUPPOSITORY
MARKETING STATUS
Discontinued

Products

NEOPAPDiscontinued
ACETAMINOPHEN 120MG · SUPPOSITORY · RECTAL

Approval history

1978-10-16Labeling · Supplement 12AP
1977-10-18Manufacturing (CMC) · Supplement 11 · standardAP
1968-11-07Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →